Shuttle Pharmaceuticals raised approximately $5.75 million through a public offering to fund its Phase II clinical trial and operations. Shuttle Pharmaceuticals Holdings, Inc. announced the closing of ...
Shuttle Pharmaceuticals (Shuttle Pharma) has dosed the first three participants in a Phase II trial of its lead therapy, Ropidoxuridine, aimed at treating glioblastoma, a malignancy of the brain. A ...
ROCKVILLE, Md., Jan. 8, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) ("Shuttle Pharma") today announced they have received the 'Safe to Proceed' letter from the U.S. Food and ...
<p> <br>One of the Prince Frederick loop shuttles will be cut back in the upcoming fiscal year, the Calvert County Board of County Commissioners decided Tuesday, April 7.<P> Beginning in July, Shuttle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback